BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

Teijin and BioVaram Form Strategic Alliance To Advance Regenerative Medicine and Implantable Medical Technologies Across Japan and India

Teijin Limited and BioVaram, the brand name of the UR Advanced Therapeutics Pvt Ltd. (URAT), announced today ...

November 13, 2025 | News

Vaxcellbio and Seoul National University Partner To Develop Next Generation DDS Formulation for Macular Degeneration Therapies

Vaxcellbio (CEO Je-Jung Lee, MD, PhD ), a leading immuno-oncology company, announced that it has entered into a strategic memorandum of underst...

November 13, 2025 | News

Terumo BCT and Santersus Partner to Advance Breakthrough Apheresis Technology for Sepsis Care

Sepsis is one of the most frequent causes of death worldwide, claiming nearly 11 million lives, accounting for 20% of all global deaths and...

November 13, 2025 | News

Genezen Partners with Humane Genomics to Manufacture Novel Oncolytic Therapy for Paediatric Liver Cancer

Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Humane Genomics, a biotechnology company developing oncolyt...

November 13, 2025 | News

MGI Tech, SAMRC and DSTI Launch Africa’s First DNBSEQ-T7 Sequencer and 110K Human Genome Program in South Africa

MGI Tech Co., Ltd., a company dedicated to developing core tools and technologies that drive innovation in life sciences, announced two historic milestones...

November 12, 2025 | News

SOPHiA GENETICS and Element Biosciences Partner to Merge Sequencing and AI Analytics for Precision Medicine

SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pac...

November 12, 2025 | News

Mabwell Secures NMPA Approval to Begin Phase II Trial of First-in-Class Anti-IL-11 Antibody for Pathological Scarring

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that its novel anti‑IL‑11 monoclonal antibody...

November 12, 2025 | News

Sanyou Bio and Yugong Bio Forge Strategic Alliance to Advance High-End Synthetic Molecular Enzymes

Sanyou Bio and Yugong Bio today announced the signing of a strategic cooperation agreement. This powerful alliance marks a significant step ...

November 12, 2025 | News

Samsung Epis Holdings Launches Epis NexLab to Advance Next-Generation Biotechnology Platforms

Samsung Epis Holdings Co., Ltd. announced the establishment of Epis NexLab Co., Ltd., a new subsidiary that will focus on the development o...

November 12, 2025 | News

OGT Launches SureSeq™ Myeloid MRD Plus NGS Panel to Enhance Detection of Residual Disease in AML

OGT announced the launch of a new next-generation sequencing (NGS) panel for Measurable Residual Disease (MRD) - the SureSeq™ Myeloid MRD Plus NGS Pa...

November 11, 2025 | News

Primrose Bio Launches Prima RNApols™ ExTend Cap AU to Enhance Self-Amplifying mRNA Vaccine Manufacturing

Primrose Bio, Inc. ("Primrose"), a company with proprietary therapeutic manufacturing technologies, announced the launch of Prima RNApols™ ...

November 11, 2025 | News

ERS Genomics Grants CRISPR/Cas9 Patent Access to Dyadic to Advance Animal-Free Protein and Enzyme Production

ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions ('Dyadic'), a global biotechnology company producing precision-...

November 11, 2025 | News

Akeso Initiates First-in-Human Trial of Personalised mRNA Vaccine AK154 for Pancreatic Cancer

Akeso, Inc. (HKEX: 9926. HK) is pleased to announce that the first patient has been dosed in a Phase I clinical trial evaluating the personalized mRNA vacc...

November 11, 2025 | News

High-Throughput Vaccine Production: The Future of Scalable, Rapid Immunisation

Vaccines remain the cornerstone of infectious disease control, but traditional development pathways are slow and resource‐intensive. Modern chall...

November 10, 2025 | Analysis

Stay Connected